Cipla Ltd. — Regulatory Filings 2021

May 14, 2021

14[th] May, 2021

(1) BSE Ltd. (2) National Stock Exchange of India Ltd. Listing Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] floor, Dalal Street Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA

(3) SOCIETE DE LA BOURSE DE LUXEMBERG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir/Madam,

Sub: Appointment of Director

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination and Remuneration Committee and subject to approval of the shareholders at the ensuing Annual General Meeting, the Board of the Directors of the Company at its meeting held today i.e. 14[th] May 2021, has approved appointment of Mr. Robert A. Stewart (DIN: 03515778) as an additional and an independent director of the Company for period of 5 years with effect from 14[th] May, 2021 to 13[th] May 2026 (both days inclusive).

The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/ CMD/ 4/ 2015 dated 9[th] September, 2015, including the brief profile of Mr. Stewart are given in Annexure A to this letter.

Thanking you,

Yours faithfully, For Cipla Limited Digitally signed by RAJENDR RAJENDRA CHOPRA A CHOPRA Date: 2021.05.14 19:14:06 +05'30'

Rajendra Chopra Company Secretary Encl.: as above

Prepared by: Nishtha Agarwal

Annexure A

		Annexure A
	Name of the Director	Robert A. Stewart
	DIN	03515778
	Reason for change viz. appointment, ~~resignation,~~ ~~removal, death or otherwise~~	Appointment of Mr. Robert A. Stewart(DIN: 03515778), as an additional and an Independent Director of the Company for a period of five (5) years w.e.f. 14thMay 2021 to 13thMay 2026 (both days inclusive);
	~~,~~
	Date of appointment /~~cessation~~ (as applicable) & term of appointment	Period of five (5) years commencing from 14thMay 2021 to 13thMay 2026. He would not be liable to retire by rotation.
	Brief profile	Robert Stewart has over 34 years of experience in the biopharmaceutical industry having worked with leading companies such as Roche, Abbott, Watson / Actavis / Allergan, Amneal and Theramex. Currently, Robert is the Chief Executive Officer at Theramex Ltd, a global specialty pharmaceutical company. Robert has deep expertise in manufacturing operations, quality, supply chain and general management and a very strong exposure to commercial operations. He has served on the boards of several industry and non-profit organizations and served for nearly two years on the Amneal board of directors. Robert has a B.S., Business Management from Fairleigh Dickinson University, New Jersey.
	Disclosure of relationships between directors (in case of appointment of a director).	Mr Robert A. Stewart has no relationship with any other directors of the company.
	Information as required pursuant to BSE Circular with ref. no. LIST/ COMP/ 14/ 2018- 19 and the National Stock Exchange of India Ltd with ref. no. NSE/ CML/ 2018/24, dated 20th June 2018	Mr. Robert Stewart is not debarred from holding the office of director by virtue of any SEBI order or any other such authority.